Get Semaglutide Prescribed Online

How Telehealth GLP-1 Prescriptions Work

Telehealth semaglutide prescribing follows the same clinical standards as in-person prescribing. A licensed provider evaluates your medical history, determines if you meet the criteria, and writes a prescription if appropriate. The difference is that the evaluation happens remotely rather than in a physical office.

The basic process at most telehealth platforms:

1. Intake form. You complete a detailed medical questionnaire: height, weight, medical conditions, medications, allergies, previous weight loss attempts, and health goals.
2. Medical evaluation. A licensed provider (physician, NP, or PA) reviews your information. Some platforms do this via video consultation. Others use asynchronous review (the provider reviews your submitted information and contacts you with questions). Both are legally valid for prescribing in most states.
3. Clinical decision. The provider determines if semaglutide is appropriate based on your BMI, medical history, and any contraindications (personal or family history of medullary thyroid carcinoma, MEN2 syndrome, pancreatitis history, etc.).
4. Prescription. If approved, the provider writes a prescription that is sent to a pharmacy (retail, specialty, or compounding depending on the platform).
5. Delivery. Medication ships to your home in temperature-controlled packaging. For storage guidance, see our storage guide.
6. Ongoing care. Legitimate platforms include follow-up consultations, dose titration management, and side effect monitoring. This is not a one-and-done prescription.

Eligibility Requirements

The prescribing criteria for semaglutide for weight management (Wegovy indication) are based on FDA labeling:

• BMI of 30 or greater (obesity), OR
• BMI of 27 or greater with at least one weight-related comorbidity: type 2 diabetes, hypertension, high cholesterol/dyslipidemia, obstructive sleep apnea, or cardiovascular disease.

For the diabetes indication (Ozempic), the criterion is a diagnosis of type 2 diabetes.

Additional clinical requirements that responsible providers assess:

• No personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
• No history of pancreatitis (relative contraindication; some providers will prescribe with monitoring)
• Not currently pregnant or planning pregnancy within 2 months
• No active gallbladder disease (semaglutide increases gallstone risk during rapid weight loss)
• No history of severe gastroparesis

If you are unsure whether you qualify, the consultation process will determine this. FormBlends evaluates every patient individually rather than applying rigid cutoffs.

What to Expect During Your Consultation

A proper medical evaluation for semaglutide should cover these areas. If a platform skips most of these, that is a concern.

Medical history review. Your provider should ask about chronic conditions, surgical history, current medications (especially insulin or sulfonylureas, which increase hypoglycemia risk with GLP-1 agonists), and relevant family history (thyroid cancer, MEN2).

Weight history. Previous weight loss attempts, diets, medications tried, and bariatric surgery history. This helps the provider understand your trajectory and set realistic expectations.

Mental health screening. Some platforms screen for eating disorders, depression, and body dysmorphia. GLP-1 medications are not appropriate for patients with active anorexia or bulimia. The appetite suppression can worsen restrictive eating patterns.

Lab discussion. Baseline labs (metabolic panel, lipid panel, A1C, thyroid function) help identify comorbidities and establish a monitoring baseline. Some providers require labs before prescribing; others initiate treatment and require labs within the first month.

Medication education. Your provider should explain the titration schedule, common side effects, injection technique, storage requirements, and when to contact them. If you are receiving a compounded formulation, reconstitution instructions should be provided.

Follow-up plan. A responsible provider sets up regular check-ins (monthly or quarterly) to monitor progress, adjust dosing, manage side effects, and ensure safety. One-time prescriptions without follow-up are a red flag.

Brand vs Compounded Semaglutide

This is the most important distinction for patients getting semaglutide online, and it is the source of significant confusion and debate in the community.

The legality question. Compounded semaglutide is legal when the FDA has designated the drug as being in shortage. Compounding pharmacies registered under Section 503A (patient-specific prescriptions) or Section 503B (larger-scale manufacturing) can produce compounded versions during shortage periods. The FDA's shortage list status determines legality. For the most current details, see our brand vs compounded comparison.

Quality considerations. Brand semaglutide undergoes FDA-mandated manufacturing standards, batch testing, and quality control. Compounding pharmacies are regulated at the state level with varying oversight intensity. Reputable 503B pharmacies follow cGMP (current Good Manufacturing Practice) standards. Quality varies between compounding pharmacies, which is why the pharmacy source matters.

FormBlends works with established compounding pharmacies that meet stringent quality standards, and provides all necessary injection supplies and instructions with each shipment.

How FormBlends Handles the Process

The FormBlends approach to prescribing semaglutide online is designed around comprehensive care, not only prescription fulfillment.

1. Online intake (5-10 minutes). Complete your medical history, current medications, and health goals through the FormBlends platform.
2. Provider review. A licensed FormBlends provider evaluates your case, checking eligibility, contraindications, and medication interactions.
3. Personalized plan. Your provider creates a treatment plan including starting dose, titration schedule, and monitoring timeline tailored to your health profile.
4. Medication shipment. Your semaglutide ships in temperature-controlled packaging with all necessary supplies (syringes, needles, alcohol swabs, sharps container for compounded formulations).
5. Ongoing monitoring. Regular check-ins with your provider to adjust dosing, manage side effects, and track progress. Your FormBlends provider is available for questions between scheduled visits.

FormBlends includes provider consultations, medication, supplies, and shipping in the treatment cost. There are no hidden fees for follow-up visits or dose adjustments.

Cost Comparison

The cost of semaglutide through insurance depends entirely on your plan. Many commercial plans now cover Wegovy for weight management, but formulary restrictions, prior authorization requirements, and step therapy (requiring you to try other treatments first) are common. For patients without coverage or with high copays, compounded semaglutide through a platform like FormBlends provides a more predictable and accessible price point.

What the Community Is Discussing

Online prescribing is one of the most debated topics in GLP-1 communities. The market is shifting rapidly as regulations evolve and new providers enter the market.

Red Flags to Watch For

Not all online semaglutide providers meet the same clinical standards. Here are warning signs that a provider may not be prioritizing your safety.

• No medical evaluation. If you can order semaglutide without any health questions, medical history review, or provider interaction, that is not telemedicine. That is an unregulated medication sale.
• No provider interaction. A licensed physician, NP, or PA should review your case. If the "provider" is an AI chatbot or an algorithm that auto-approves everyone, the prescribing standard is not being met.
• Extremely low prices. Semaglutide has real costs (raw ingredient, compounding, quality testing, provider time, shipping). Prices significantly below $150/month should prompt questions about medication quality and concentration.
• No follow-up plan. A one-time prescription without dose titration management, side effect monitoring, or check-ins is inadequate care. GLP-1 treatment requires ongoing management.
• No contraindication screening. If nobody asks about thyroid cancer history, pancreatitis, pregnancy, or current medications, the safety screening is missing.
• Pressure to commit quickly. Legitimate providers do not use countdown timers, limited-time pricing, or pressure tactics. Medical decisions should not be rushed.
• Unverifiable pharmacy source. You should be able to verify that the compounding pharmacy is state-licensed and FDA-registered. If the provider will not disclose their pharmacy partner, that is a concern.

State Laws and Telehealth Regulations

Telehealth prescribing is legal in all 50 states, but regulations vary. The key requirements:

Provider licensing. The prescribing provider must hold an active medical license in the state where the patient is located at the time of the consultation. This is the patient's state, not the provider's state. Multi-state platforms maintain provider networks licensed across all states they serve.

Standard of care. The telehealth consultation must meet the same standard of care as an in-person visit. This means a proper medical evaluation, documentation, and follow-up. Most states have adopted the Interstate Medical Licensure Compact, which makes multi-state licensing easier for providers.

Prescribing modality. Some states require an initial video consultation before prescribing. Others allow asynchronous (questionnaire-based) evaluations for certain medication categories. FormBlends complies with the prescribing requirements of each state in which it operates.

Controlled substance considerations. Semaglutide is not a controlled substance, which simplifies telehealth prescribing compared to medications like phentermine (a Schedule IV controlled substance also used for weight management). The DEA telehealth prescribing rules for controlled substances do not apply to semaglutide.

Frequently Asked Questions